Mark Walterfang Selected Research

Mark Walterfang Research Topics

Disease

13	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2022 - 01/2006
7	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022 - 01/2006
6	Dementia (Dementias) 11/2022 - 12/2006
6	Frontotemporal Dementia (Semantic Dementia) 10/2022 - 05/2012
5	Atrophy 12/2018 - 12/2006
4	Schizophrenia (Dementia Praecox) 10/2022 - 12/2006
4	Psychotic Disorders (Schizoaffective Disorder) 04/2012 - 01/2006
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2014
3	Cognitive Dysfunction 01/2022 - 12/2018
3	Deglutition Disorders (Dysphagia) 01/2021 - 10/2012
3	Phenylketonurias (Phenylketonuria) 01/2021 - 07/2013
3	Disease Progression 01/2020 - 07/2012
2	Traumatic Brain Injuries (Traumatic Brain Injury) 08/2022 - 07/2020
2	Wounds and Injuries (Trauma) 04/2022 - 06/2020
2	Feeding and Eating Disorders (Eating Disorder) 04/2022 - 06/2020
2	Mental Disorders (Mental Disorder) 01/2022 - 01/2020
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2020 - 08/2009
2	Aspiration Pneumonia 01/2018 - 10/2012
2	Neurologic Manifestations (Neurological Manifestations) 01/2018 - 10/2012
2	Cerebrotendinous Xanthomatosis 04/2014 - 07/2013
2	Inborn Urea Cycle Disorders 04/2014 - 07/2013
2	Acute Intermittent Porphyria (Porphyria, Acute) 04/2014 - 07/2013
2	Hepatolenticular Degeneration (Wilson's Disease) 04/2014 - 01/2013
2	Neuroacanthocytosis 04/2014 - 04/2011
2	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 07/2013 - 01/2013
2	Epilepsy (Aura) 12/2010 - 12/2007
2	Brain Diseases (Brain Disorder) 07/2008 - 01/2007
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 11/2022
1	Treatment-Resistant Schizophrenia 10/2022
1	Confusion (Bewilderment) 08/2022
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2022
1	Lewy Body Disease (Lewy Body Dementia) 01/2022
1	Neurobehavioral Manifestations 01/2021
1	succinic semialdehyde dehydrogenase deficiency 01/2020
1	Neuroinflammatory Diseases 01/2020
1	Major Depressive Disorder (Major Depressive Disorders) 01/2020
1	Mood Disorders (Mood Disorder) 01/2020
1	Perceptual Disorders (Hemispatial Neglect) 02/2018
1	Hyperammonemia 01/2018
1	Homocystinuria 04/2014
1	Homocysteinemia 04/2014
1	Ataxia (Dyssynergia) 04/2014
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2014
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 07/2013
1	Maple Syrup Urine Disease 07/2013
1	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 07/2013
1	alpha-Mannosidosis 07/2013
1	GM2 Gangliosidoses (GM2 Gangliosidosis) 07/2013
1	Huntington Disease (Huntington's Disease) 01/2013
1	Weight Loss (Weight Reduction) 01/2013
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2013
1	Binge-Eating Disorder (Binge Eating Disorder) 01/2013
1	Anorexia 01/2013
1	Bulimia Nervosa 01/2013
1	Alcoholism (Alcohol Abuse) 12/2012
1	Central Pontine Myelinolysis 12/2012

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 11/2022 - 05/2012
7	miglustat (Zavesca)FDA Link 01/2021 - 10/2012
7	LipidsIBA 01/2018 - 07/2008
4	CholesterolIBA 01/2022 - 01/2006
3	IronIBA 01/2018 - 12/2006
2	Olanzapine (Zyprexa)FDA Link 08/2022 - 07/2020
2	Selenic AcidIBA 01/2022 - 11/2020
2	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 01/2021 - 01/2019
2	HomocysteineIBA 04/2014 - 07/2013
2	Neurotransmitter Agents (Neurotransmitter)IBA 07/2013 - 12/2007
2	Biological ProductsIBA 12/2007 - 09/2006
1	Clozapine (Clozaril)FDA LinkGeneric 10/2022
1	Proteins (Proteins, Gene)FDA Link 10/2022
1	N 30IBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	C-Reactive ProteinIBA 01/2020
1	LigandsIBA 01/2020
1	MelatoninIBA 01/2020
1	Succinate-Semialdehyde Dehydrogenase (Succinic Semialdehyde Dehydrogenase)IBA 01/2020
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2019
1	Hallucinogens (Psychedelics)IBA 02/2018
1	CopperIBA 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 04/2014
1	Phosphotransferases (Kinase)IBA 04/2014
1	Niemann-Pick C1 ProteinIBA 03/2014
1	MetalsIBA 03/2014
1	MonosaccharidesIBA 01/2013
1	Topiramate (Topamax)FDA LinkGeneric 01/2013
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2013
1	sulfamic acid (ammonium sulfamate)IBA 01/2013
1	SodiumIBA 12/2012
1	GlycosphingolipidsIBA 07/2012
1	LithiumIBA 04/2012
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2011
1	Valproic Acid (Depakote)FDA LinkGeneric 12/2010
1	Temazepam (Nocturne)FDA LinkGeneric 03/2010
1	Antipsychotic Agents (Antipsychotics)IBA 03/2010
1	Carrier Proteins (Binding Protein)IBA 08/2009
1	UbiquitinIBA 08/2009

Therapy/Procedure

5	Therapeutics 01/2020 - 07/2011
1	Home Nursing (Nursing, Home) 06/2022
1	Activities of Daily Living (ADL) 01/2020